Clinical Trial: ECOG-ACRIN MM1OA-EA02

ECOG-ACRIN MM1OA-EA02

Status: New, Open

A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial

(See required screening study MYELOMATCH)